Risk Assessment Strategy / Tools & Technology

Topic	Replies	Views	Activity
Carcinogenic Potency Database - Access free With discussions about limits and how they are establish, it’s an important reminder about the Carcinogenic Potency Database, now The Lhasa Carcinogenicity Database (LCDB). Below from Lhasa article: “5 things you should…	2	2571	July 13, 2022
About the Risk Assessment Strategy / Tools & Technology category	0	673	April 14, 2021
Why Regulators Are Questioning Paper-Only Risk Assessments risk-assessment	4	143	October 20, 2026
Managing nitrosamine toxicological risk in late-stage development NDSRI	1	144	October 15, 2026
Call to review USP Risk Assessment Review Toolbox	127	4369	October 2, 2026
Theoretical evaluation of NDSRIs Drug_Substance_APIs , NDSRI	13	687	September 25, 2026
From Detection to Prediction: AI-driven Process Analytical Technology for Nitrosamine and NDSRI Control in Pharmaceuticals-Pub NDSRI	0	180	August 19, 2026
QSAR Toolbox - Free software. Any experience?	22	2753	July 31, 2026
Integrating nitrosamine theoretical formation into Translational Pharmaceutics: Mitigating risks during accelerated formulation development in early phase clinical studies-Pub risk-assessment	0	150	July 28, 2026
Less than daily administration	7	522	July 19, 2026
Nitrosamine risk assessment in early clinical development	0	236	June 17, 2026
Removal of nitrosamine analysis from the specification	3	349	April 24, 2026
Excipient Selection Strategies to Mitigate Nitrosamine Risks Excipients	0	278	April 8, 2026
Excipient Nitrosamine Risk Assessment Tool	1	584	March 26, 2026
Limit Test for NDSRI Risk Assessment?	3	299	March 13, 2026
Chat GPT's answer about the risk assessment of nitrosamine in pharmaceuticals	33	4162	February 28, 2026
Nitrosamine Risk Assessment on DETA	0	191	February 22, 2026
Available Tools for Prediction of Potential Degradation Products from Nitrosation Reactions Drug_Substance_APIs , risk-assessment , NDSRI	4	354	February 4, 2026
Nitrosamine Purge Factor Calculation Drug_Substance_APIs	1	564	December 30, 2025
The Impact of API Synthesis Optimization on Reducing Nitrosamine Risk: A Technical Walkthrough risk-assessment	0	297	December 20, 2025
⚖️ Risk assessment not strong enough, specifically on related impurities containing secondary amine	24	2569	September 25, 2025
Stability in risk assessment report risk-assessment	12	799	September 10, 2025
Background on Purging Factor Calculation for your Risk Assessment purge	7	2132	August 13, 2025
Nitrosamine Risk Mitigation Calculator (by DFE Pharma) NDSRI , featured	1	1717	August 11, 2025
Nitrosamines evaluation in transdermal patches	12	2301	July 16, 2025
CMO Nitrosamine Risk Assessment Drug_Substance_APIs , NDSRI , risk-assessment	7	593	June 27, 2025
How to decide if one anticancer drug is for advanced cancer? risk-assessment	12	921	June 13, 2025
📖 Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines-Pub risk-assessment , featured	2	1282	May 27, 2025
Can we bypass confirmatory testing of DP based on Theoretical Calc. of NDSRI's	9	1592	April 24, 2025
Nitrosamines in topical products	4	1369	April 15, 2025

Carcinogenic Potency Database - Access free

With discussions about limits and how they are establish, it’s an important reminder about the Carcinogenic Potency Database, now The Lhasa Carcinogenicity Database (LCDB). Below from Lhasa article: “5 things you should…